Prof. Dr. Alexander Navarini-Meury, Chief of Dermatology at University Hospital Basel excited to have the 1st VECTRA® WB360 in Switzerland.
In the News
The Skin Cancer Foundation kicks off its mobile education and screening program, Destination Healthy Skin, in their 38-foot RV customized with two consultation rooms with Canfield’s Reveal® Imager for consultations.
Canfield's new IntelliStage® intelligent turntable enables users to easily capture 360° 3D images and videos. Designed to integrate with the Canfield VECTRA® H2 and IntelliStudio®, the IntelliStage’s sleek, ergonomic design rotates patients comfortably throughout all necessary captures.
Dr. Oz tested effectiveness of the popular trend - sheet face masks. Using the VISIA Complexion Analysis device, two women were analyzed to see their results before applying the face mask, immediately after removing the mask, and 1 hour later.
University of Queensland received a $10 million grant to install 15 VECTRA® WB360 whole body imaging systems across Queensland, New South Wales and Victoria. This grant will help revolutionize teledermatology skin screenings .
This fall marked Canfield's 10th installation of the VECTRA® WB360. Check out where all of these systems have been installed:
Revolutionizing skin care consultations for over ten years, the VISIA® Complexion Analysis System has been voted best-in-class by aestheticians world-wide for 2018, and has been nominated again for 2019.
Canfield Scientific was featured on Australia's eyewitness NEWS 10 talking about the first installation and use of the newly designed IntelliStudio® in Perth, Australia!
Demonstrating its continued commitment and leadership in photographic skin imaging, Canfield Scientific announced the acquisition of German company VISIOMED AG - the leading designer and manufacturer of dermoscopy systems. The resulting business has decades of experience in aesthetic documentation, 3D imaging, clinical photography and reflected light microscopy leading to more choices and services for customers.
Early detection of melanoma research has received a $1.195 million Partnership Grant from the National Health and Medical Research Council (NHMRC). The project, led by University of Queensland Diamantina Institute researcher Professor H. Peter Soyer, will use teledermatology to improve early detection of melanoma in high-risk patients. Professor Soyer’s study is a collaboration between UQ, Metro South Hospital and Health Service (through the Princess Alexandra Hospital), QIMR Berghofer Medical Research Institute, Cancer Council Queensland, Queensland University of Technology and Canfield Scientific Inc.
